Balance Sheet for Global Blood Therapeutics Inc. (GBT)

$ 71.12   1.78 (+2.57%) Volume: 764.03k 4:00 PM EDT Jul 10, 2020
After Hours:  $ 71.4328   0.3128 (+0.44%) Volume: 1.85k 4:11 PM EDT Jul 10, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 302,237 275,357 198,332 92,072 148,502
Restrictable Cash - - - - -
Marketable Securities 307,732 202,177 116,493 55,202 -
Accounts Receivable 2,637 - - - -
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 2,637 - - - -
Inventories, Raw Materials 700 - - - -
Inventories, Work in Progress 525 - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 52 - - - -
Inventories, Other 1,277 - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories 1,277 - - - -
Prepaid Expenses 9,422 6,337 3,839 1,983 1,222
Current Deferred Income Taxes - - - - -
Other Current Assets 4,692 1,909 5,648 512 1,096
Total Current Assets 627,997 485,780 324,312 149,769 149,724
Land and Improvements - - - - -
Buildings and Improvement 13,785 13,785 12,642 678 340
Machinery, Furniture and Equipment 10,538 8,864 7,309 4,867 3,747
Construction in Progress 19,289 239 419 137 129
Fixed Assets, Other 52,775 - - - -
Fixed Assets, Total 96,387 22,888 20,370 5,682 4,216
Gross Fixed Assets 96,387 22,888 20,370 5,682 4,216
Accumulated Depreciation (16,499) (7,907) (3,799) (3,262) (2,102)
Net Fixed Assets 79,888 14,981 16,571 2,420 2,114
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 3,184 2,601 1,230 140 140
Total Non-Current Assets 168,102 131,863 32,408 52,618 2,254
Total Assets 796,099 617,643 356,720 202,387 151,978
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 10,651 6,076 7,174 4,320 3,254
Short Term Debt 1,866 - - - -
Notes Payable - - - - -
Accrued Expenses 41,358 16,792 10,135 5,319 3,411
Accrued Liabilities 41,358 16,792 10,135 5,319 3,411
Deferred Revenues - - - - -
Current Deferred Income Taxes - - - - -
Other Current Liabilities 17,578 10,905 8,955 5,876 2,962
Total Current Liabilities 71,453 33,773 26,264 15,515 9,627
Long Term Debt 73,559 N/A N/A - -
Deferred Income Tax - 11,041 11,491 29 86
Other Non-Current Liabilities 34 11,071 11,652 563 (103,998)
Minority Interest - - - - -
Capital Lease Obligations 72,359 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - 105,554
Total Non-Current Liabilities 145,952 11,071 11,652 563 1,556
Total Liabilities 217,405 44,844 37,916 16,078 11,183
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 578,694 572,799 318,804 186,309 140,795
Common Par 61 56 46 37 29
Additional Paid in Capital 1,316,795 1,044,941 617,051 367,371 239,231
Cumulative Translation Adjustments - - - - -
Retained Earnings (738,916) (472,150) (297,957) (180,933) (98,465)
Treasury Stock - - - - -
Other Equity Adjustments 754 (48) (336) (166) -
Total Capitalization 652,253 572,799 318,804 186,309 140,795
Total Equity 578,694 572,799 318,804 186,309 140,795
Total Liabilities & Shareholder's Equity 796,099 617,643 356,720 202,387 151,978
Cash Flow (274,641) (178,140) (119,386) (83,777) (46,360)
Working Capital 556,544 452,007 298,048 134,254 140,097
Free Cash Flow (197,877) (140,199) (96,123) (69,075) (31,883)
Invested Capital 652,253 572,799 318,804 186,309 140,795
Shares Outstanding - Common Class Only 60,644 55,640 46,132 36,638 29,360
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 60,644 55,640 46,132 36,638 29,360
Total Common Shares Outstanding 60,644 55,640 46,132 36,638 29,360
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 58,322 51,151 42,324 33,207 12,807
Diluted Weighted Shares Outstanding 58,322 51,151 42,324 33,207 12,807